NCT00958464

Completed

The Effect of Perthes' Disease on Hip Cartilage

University of British Columbia Source

Compare

Other study identifiers

Sponsor study identifier

H07-00930

Study Type

observational

Actual enrollment (reported)

20

Locations

1 country

Sites

1

Timeline

Study Start

January 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2017

Actual (reported)

Study Completion

June 2017

Actual (reported)

Brief Summary

The purpose of this study is to determine whether Perthes' disease has caused detectable hip cartilage damage in young people who have reached the healed stage of the disease.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 20 participants
Study completion date: June 2017
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2008
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
August 11, 2009
Actual (reported)
First Posted
August 13, 2009
Actual (reported)
Primary Completion
June 2017
Actual (reported)
Study Completion
June 2017
Actual (reported)

Last Updated: October 3, 2019
Status Verified: October 2019
Last Update Submitted: October 2, 2019

Conditions

Perthes' Disease

Keywords

MRIPerthes'diseasehipcartilage

Outcome Measures

Primary Outcomes (1)

Whether Perthes' disease has caused detectable hip cartilage damage in young people who have reached the healed stage of the disease.
2 days

Study Arms (1)

1

MRI protocol on 2 separate occasions

Procedure: MRI

Interventions

MRIProcedure

MRI protocol consists of intravenous injection of 0.4 ml/kg dose of gadopentetate dimeglumine 2- \[Gd-DTPA2-\] contrast agent (Magnevist, Bayer) 90 minutes prior to imaging.

1

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age17 Years - 18 Years

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64)

Sampling MethodNon-Probability Sample

Study Population

Volunteers with healed unilateral Perthes' disease between the ages of 7-18 years

You may qualify if:

Subjects must have reached the healed stage of unilateral Perthes' disease. -Subjects will be between 7 and 18 years of age.

Sponsors & Collaborators

University of British Columbia
Otherlead

Study Sites (1)

BC Children's Hospital, Department of Orthopaedics

Vancouver, British Columbia, Canada

MeSH Terms

Conditions

Legg-Calve-Perthes Disease

Condition Hierarchy (Ancestors)

Femur Head NecrosisOsteonecrosisBone DiseasesMusculoskeletal Diseases

Study Officials

Kishore Mulpuri, Dr.
University of British Columbia
PRINCIPAL INVESTIGATOR
David Wilson, Dr.
University of British Columbia
STUDY DIRECTOR

Enrollment

20 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principle Investigator

Study Record Dates

First Submitted

August 11, 2009

First Posted

August 13, 2009

Study Start

January 2008

Date type not reported

This date has not been verified as actual or estimated.

NCT02676271

The Long Term Outcome of Varus Derotational Osteotomy for Legg-Calvé-Perthes' Disease

Completed

NCT07122323

Robotic Arm-assisted THA Vs. Conventional THA in Legg-Calvé-Perthes Disease

Not ApplicableEnrolling By Invitation

NCT00291304

Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma

Phase 2Terminated

NCT05840146

Kineesiotaping for Patients With LCPD

Not ApplicableCompleted

NCT00297024

Radiotherapy - Cerebrovascular Reactivity (RT-CVR Study)

Phase 2Completed

NCT00610181

Magnetic Resonance Imaging in Patients With Breast Cancer

Completed

Subjects must understand English.

You may not qualify if:

Subjects will be excluded if they have bilateral Perthes' disease or if they have not yet reached the healing stage of the disease.
Subjects will also be excluded if they do not meet the criteria to have an MRI (e.g., the subject has metal implants, is claustrophobic, has a metallic object in eye or a pacemaker).
A subject will be excluded if they have any of the precautions for the MR contrast agent, Magnevist, such as pregnancy, breast-feeding, respiratory allergies, asthma, thrombotic syndromes, history of grand mal seizures, impaired renal or hepatic function.

Contact the study team to confirm eligibility.

Primary Completion

June 2017

Actual (reported)

Study Completion

June 2017

Actual (reported)

Last Updated

October 3, 2019

Record last verified: 2019-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00958464
Data provider: ClinicalTrials.gov
Source updated: 2019-10-03
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:34:16 UTC

Locations

CA(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

1

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations